Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: CERT

Certara, Inc.

Healthcare | Medical - Healthcare Information Services

No licensed closing price on file for CERT. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-0.45

Certara, Inc. (NASDAQ: CERT) is a health information company. Figures from SEC EDGAR; updated 2026-10-20 16:23 UTC.

What Certara, Inc. does

Certara is a global provider of biosimulation science, technology, and consulting services that help biopharmaceutical and biotech companies use Model-Informed Drug Development to make decisions during drug research, development, and commercialization. The company's approach combines mathematical and biological modeling with expert interpretation and regulatory expertise to help reduce development costs and increase the probability of drug approval.

Summarized from Certara, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-0.45
Debt/equity0.30

Revenue, margins & earnings

FY2021: net loss $13M on revenue $286M$286MFY2021FY2022 Net income: $15MFY2022 Taxes & interest: $18MFY2022 Operating costs: $303M$336MFY2022FY2023: net loss $55M on revenue $354M$354MFY2023FY2024: net loss $12M on revenue $385M$385MFY2024FY2025: net loss $2M on revenue $419M$419MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-02
  • 2026-09-02Interim CFORestricted Stock UnitsAward63,532—
  • 2026-06-02Chief Human Resources OfficerRestricted Stock UnitsOption exercise-7,147—
  • 2026-06-02SVP and General CounselOption exercise7,941—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Certara, Inc. do?

Certara is a global provider of biosimulation science, technology, and consulting services that help biopharmaceutical and biotech companies use Model-Informed Drug Development to make decisions during drug research, development, and commercialization.

When did CERT last file with the SEC?

Certara, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-17. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 16:23 UTC. This page is also available as JSON at /api/data?ticker=CERT and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for CERT and 5,000+ tickers.

Create a free account — keep CERT
For your agent
GET /api/data?ticker=CERT

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt